Advanced Oncotherapy 股票

Advanced Oncotherapy 员工 2024

Advanced Oncotherapy 员工

129

股票代码

AVO.L

ISIN

GB00BD6SX109

WKN

A2AL9X

在2024年,Advanced Oncotherapy雇佣了129名员工,相较于前一年员工数量0,发生了0%的变化。

Advanced Oncotherapy Aktienanalyse

Advanced Oncotherapy在做什么?

上的 Advanced Oncotherapy PLC is a therapeutic company in London, specializing in the development of advanced and precise radiation therapy solutions. The company was founded in 2005 and has since developed a revolutionary technology that allows for the treatment of cancer cells with the highest precision and minimal to no damage to surrounding tissues. Advanced Oncotherapy's business model aims to provide innovative technology solutions that benefit patients throughout their cancer treatment. The company's various branches include research and development, production, sales and distribution, and clinical trials. Advanced Oncotherapy focuses on a direct customer-client relationship by offering customers interesting treatment options that are tailored to the patient's needs. The flagship product of Advanced Oncotherapy is the LIGHT radiation therapy system, which is globally unique due to its precision, accuracy, and effectiveness in the treatment of cancer. With this system, oncologists and radiologists are able to perform innovative radiation therapy that promises better treatment outcomes. The LIGHT technology is based on the principles of intensity-modulated radiation therapy (IMRT) and next-generation particle therapy (NGPT). By using proton beams, radiation therapy can be focused directly on a specific region of the body where cancerous tissue is spreading. Advanced Oncotherapy offers a wide range of services in the field of radiation therapy, including proton accelerators (PROTON), PET/CT systems (positron emission tomography/computed tomography), CT scanners (computed tomography), and other tools and devices. This product line has been specifically developed for the precise radiation of tumors and for the diagnosis of cancer and other related diseases. Advanced Oncotherapy's customers are primarily hospitals, medical centers, and health authorities. In recent years, Advanced Oncotherapy has collaborated closely with various partners such as CERN (European Organization for Nuclear Research), the Royal Marsden Hospital, University College London, and other institutions to continuously improve and develop its technology and products. Milestones in the company's history include the granting of CE marking for the LIGHT system and support for clinical trials through research-intensive university hospitals. The future of Advanced Oncotherapy looks promising, with a strong growth forecast for the global radiation therapy market. With an increasing demand for innovative solutions for cancer treatment, the company can look forward to a growing customer base and an increasing number of partnerships and collaborations. Advanced Oncotherapy will continue to focus on continuously optimizing its technology to provide cancer patients with the best treatment options. Advanced Oncotherapy ist eines der beliebtesten Unternehmen auf Eulerpool.com.

员工的详细信息

Advanced Oncotherapy的员工基础调查

Advanced Oncotherapy的员工是其运营的关键因素,推动了创新、生产力和增长。员工队伍的规模和组成提供了公司规模、多样性以及人力资本投资的见解。分析员工数据对于理解Advanced Oncotherapy的运营能力和未来潜力至关重要。

年度对比

通过年度比较Advanced Oncotherapy的员工数量,有助于发现增长模式、扩张或者收缩。员工数量的增加可能表明运营正在扩大并投资于人才,而员工数量的减少可能表明效率提升、自动化或商业挑战。

对投资的影响

Advanced Oncotherapy的员工数据会影响投资决策,通过揭示公司运行效率、创新能力和持续性。投资者评估员工数据,以评估公司实施策略、创新以及适应市场变化的潜力。

员工数据的解读

Advanced Oncotherapy的员工数量的波动可能表明商业策略、运营需求以及市场动态的变化。投资者和分析师会研究这些趋势,以评估公司的战略定位、适应能力以及持续增长的潜力。

关于Advanced Oncotherapy股票的常见问题

Advanced Oncotherapy今年有多少员工?

Advanced Oncotherapy今年有129 undefined名员工。

Advanced Oncotherapy去年相比有多少员工?

与去年相比,Advanced Oncotherapy的员工数量增加了0%。

员工数量对Advanced Oncotherapy公司产生了什么影响?

员工数量直接影响了Advanced Oncotherapy的效率和生产力。较高的员工数量可能意味着公司正在发展并拥有更多资源以实现其目标,而较低的员工数量可能意味着公司正在节约成本或在招聘新员工方面有困难。

Advanced Oncotherapy的员工数量对投资者产生了什么影响?

Advanced Oncotherapy的员工数量也可能影响投资者,因为它可能是公司增长和财务健康的指标。较高的员工数量可能向投资者承诺,而较少的员工数量可能会引发关注。

Advanced Oncotherapy的股本增加会对公司产生什么影响?

增加Advanced Oncotherapy的股本可以提高公司的财务实力,并提高其未来进行投资和履行义务的能力。

Advanced Oncotherapy的股本减少会对公司产生什么影响?

降低Advanced Oncotherapy的股本可能会影响其财务稳定性,并降低其履行未来投资和义务的能力。

Advanced Oncotherapy的股权受到哪些因素的影响?

一些可能影响Advanced Oncotherapy股本的因素包括营业收入发展、利润及损失表、派发股息和投资等。

为什么Advanced Oncotherapy的股权对投资者如此重要?

Advanced Oncotherapy的股本对投资者来说非常重要,因为它是公司财务稳定性的指标,并且它向投资者提供了有关该公司在义务和未来投资方面有多少财务支持的信息。

Advanced Oncotherapy的员工数量如何影响公司?

Advanced Oncotherapy的员工数量可以直接影响公司的增长和表现。更多的员工数量可能会带来更大的产能和生产力,而较少的员工数量可能会导致效率下降和限制。

Advanced Oncotherapy在过去几年的员工人数有何变化?

在过去的几年中,Advanced Oncotherapy的员工数量发生了NaN的变化。

Advanced Oncotherapy目前有多少员工?

Advanced Oncotherapy目前有129 undefined名员工。

为什么Advanced Oncotherapy的员工人数对投资者来说很重要?

Advanced Oncotherapy的投资者认为员工数量非常重要,因为它是公司增长潜力和绩效的指标。还有关于公司如何管理和招聘员工的信息。

Advanced Oncotherapy可以采取哪些战略措施来改变员工数量?

为了改变员工数量,Advanced Oncotherapy可以采取包括调整薪酬包,改善工作条件,进行招聘活动,和推动积极企业文化等措施。公司需要进行全面的情况审查,以确定最佳战略措施来改变其员工数量,这一点非常重要。

Advanced Oncotherapy支付多少股息?

在过去的12个月中,Advanced Oncotherapy支付了 的股息。这相当于大约的股息收益率。在未来的12个月内,Advanced Oncotherapy预计将支付0 GBP的股息。

Advanced Oncotherapy的股息收益率有多高?

Advanced Oncotherapy当前的股息收益率为。

Advanced Oncotherapy什么时候支付股息?

Advanced Oncotherapy按季度支付股息。这些股息将在月份分发。

Advanced Oncotherapy的股息有多安全?

Advanced Oncotherapy 在过去0年里每年都支付了股息。

Advanced Oncotherapy的股息有多高?

预计未来12个月的股息将达到0 GBP。这相当于0 %的股息收益率。

Advanced Oncotherapy位于哪个行业?

Advanced Oncotherapy 被分配到“健康”板块。

Wann musste ich die Aktien von Advanced Oncotherapy kaufen, um die vorherige Dividende zu erhalten?

要获得Advanced Oncotherapy在支付的0 GBP的最后一笔股息,你必须在的除息日之前持有该股票于你的账户中。

Advanced Oncotherapy最后一次支付股息是什么时候?

上一次股息发放日期为。

Advanced Oncotherapy在2023年的股息是多少?

在2023年,Advanced Oncotherapy 分配了0 GBP作为股息。

Advanced Oncotherapy 的股息是以哪种货币支付的?

Advanced Oncotherapy的股息将以GBP的形式分配。

股票储蓄计划为投资者提供了一种吸引人的方法,可以长期累积财富。主要优势之一是所谓的成本平均效应:通过定期投入固定金额于股票或股票基金,当价格低时自动买入更多份额,价格高时买入较少,这可能随着时间带来更优惠的平均每份成本。此外,股票储蓄计划还允许小额投资者接触到高价股票,因为他们可以用很小的金额参与其中。定期投资也促进了一种纪律投资策略,并有助于避免情绪化的决策,如冲动买卖。除此之外,投资者还能从股票的潜在增值以及可以再投资的股息分红中获益,这增强了复利效应,从而增加了投资资本的增长。

Andere Kennzahlen von Advanced Oncotherapy

我们对Advanced Oncotherapy 营业额股票的股票分析包括重要的财务指标,如收入、利润、市盈率、市销率、息税折旧摊销前利润,以及有关股息的信息。此外,我们还研究了诸如股票、市值、债务、股东权益和Advanced Oncotherapy 营业额的负债等方面。如果您在寻找关于这些主题的更详细信息,我们在子页面上提供了详细的分析: